J Investig Med. 2025 May 30:10815589251348911. doi: 10.1177/10815589251348911. Online ahead of print. ABSTRACT BACKGROUND: This study aimed to explore the potential causal relationship between frailty …
Cell Biol Int. 2025 May 30. doi: 10.1002/cbin.70042. Online ahead of print. ABSTRACT Pediatric respiratory diseases, ranging from acute infections to chronic lung conditions, pose …
Stem Cell Res Ther. 2025 May 30;16(1):268. doi: 10.1186/s13287-025-04404-4. ABSTRACT BACKGROUND: This study evaluated the effectiveness of intrathecal autologous bone marrow mononuclear cell (BMMNC) therapy …
J Health Popul Nutr. 2025 May 29;44(1):178. doi: 10.1186/s41043-025-00946-8. ABSTRACT BACKGROUND: Although prior studies alluded to the association between inflammatory bowel disease (IBD) and osteoporosis, …
Ital J Pediatr. 2025 May 30;51(1):165. doi: 10.1186/s13052-025-02004-9. ABSTRACT BACKGROUND: In Ecuador, pneumonia is a significant pediatric health challenge and a leading cause of infant …
J Health Popul Nutr. 2025 May 29;44(1):176. doi: 10.1186/s41043-025-00881-8. ABSTRACT BACKGROUND: Hypovitaminosis D or vitamin D deficiency is a significant public health issue. Several vitamin …
Mol Cancer. 2025 May 30;24(1):154. doi: 10.1186/s12943-025-02352-4. ABSTRACT Epigenetic modulators in combination with proapoptotic drugs have become the standard of care treatment in hematological malignancies. …
Mol Cancer. 2025 May 29;24(1):153. doi: 10.1186/s12943-025-02365-z. ABSTRACT Paediatric bone sarcomas (e.g. Ewing sarcoma, osteosarcoma) comprise significant biological and clinical heterogeneity. This extreme heterogeneity affects …
BMC Rheumatol. 2025 May 29;9(1):64. doi: 10.1186/s41927-025-00515-w. ABSTRACT BACKGROUND: Canakinumab, an IL-1β inhibitor, has demonstrated long-term efficacy and safety in patients with sJIA, FMF, TRAPS, …
Acta Epileptol. 2025 May 29;7(1):32. doi: 10.1186/s42494-025-00216-4. ABSTRACT BACKGROUND: Unverricht-Lundborg disease (ULD) is a rare autosomal recessive neurodegenerative disorder, often caused by biallelic promoter expansions …
